Mesenchymal Stromal Cells Improve the Transplantation Outcome of CRISPR-Cas9 Gene-Edited Human HSPCs

Researchers developed a mesenchymal stromal cell-based co-culture system to optimize transplantation outcome of CRISPR-Cas9 gene-edited human hematopoietic stem and progenitor cells.